University of Vermont

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1791-01-01

Employees: 51

Market Cap: -

Website: http://www.uvm.edu

Clinical Trials

Internet Assisted Obesity Treatment

Not Applicable

Completed

Conditions: Obesity
Overweight

Interventions: Behavioral: internet, in-person and internet+in-person

First Posted Date: 2005-12-15

Last Posted Date: 2019-08-06

Lead Sponsor: University of Vermont

Target Recruit Count: 481

Registration Number: NCT00265954

Locations: 🇺🇸
University of Arkansas for the Medical Sciences, Little Rock, Arkansas, United States
🇺🇸
University of Vermont, Burlington, Vermont, United States

Weight Loss on the Web: A Pilot Study Comparing a Commercial Website to a Structured Behavioral Intervention

Not Applicable

Completed

Conditions: Obesity
Diet Therapy
Weight Loss

First Posted Date: 2005-12-07

Last Posted Date: 2010-01-22

Lead Sponsor: University of Vermont

Registration Number: NCT00263172

Locations: 🇺🇸
Behavioral Weight Management Program/Univ of Vermont, Burlington, Vermont, United States

Evaluation of an Outpatient Modified Prescription Form

Not Applicable

Completed

Conditions: Medication Errors

First Posted Date: 2005-11-21

Last Posted Date: 2011-12-15

Lead Sponsor: University of Vermont

Target Recruit Count: 84

Registration Number: NCT00256594

Locations: 🇺🇸
University of Vermont, Division of General Internal Medicine, Burlington, Vermont, United States

Outpatient Prescription Errors: Detection, Analysis, and Impact on Safety

Completed

Conditions: Medication Errors

Interventions: Behavioral: reporting system

First Posted Date: 2005-11-21

Last Posted Date: 2011-12-15

Lead Sponsor: University of Vermont

Target Recruit Count: 103

Registration Number: NCT00256568

Locations: 🇺🇸
University of Vermont, Division of General Internal Medicine, Burlington, Vermont, United States

Quetiapine for the Treatment of Insomnia in Alzheimer's Disease

Not Applicable

Conditions: Alzheimer's Disease
Insomnia

First Posted Date: 2005-10-04

Last Posted Date: 2009-05-05

Lead Sponsor: University of Vermont

Target Recruit Count: 18

Registration Number: NCT00232570

Locations: 🇺🇸
Fletcher Allen Health Care-Clinical Neuroscience Research Unit, Burlington, Vermont, United States

Using Telephone Technology to Prevent Relapse After Alcoholism Treatment

Phase 2

Completed

Conditions: Alcoholism

Interventions: Behavioral: Daily monitoring of alcohol & drug use, & therapy skills
Behavioral: control group

First Posted Date: 2005-08-22

Last Posted Date: 2012-06-21

Lead Sponsor: University of Vermont

Target Recruit Count: 158

Registration Number: NCT00132795

Locations: 🇺🇸
UVM Health Behavior Research Center, Burlington, Vermont, United States

Epidemiology of Vascular Inflammation & Atherosclerosis

Completed

Conditions: Cardiovascular Diseases
Heart Diseases
Atherosclerosis
Coronary Arteriosclerosis
Coronary Disease
Cerebral Arteriosclerosis
Cerebrovascular Accident

First Posted Date: 2004-07-19

Last Posted Date: 2013-09-27

Lead Sponsor: University of Vermont

Target Recruit Count: 931

Registration Number: NCT00087893

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

Phase 2

Completed

Conditions: Leukemia
Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-26

Lead Sponsor: University of Vermont

Registration Number: NCT00005579

Locations: 🇺🇸
Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States
🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

and more 1 locations

Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease

Not Applicable

Completed

Conditions: Crohn's Disease

First Posted Date: 1999-10-19

Last Posted Date: 2015-03-25

Lead Sponsor: University of Vermont

Target Recruit Count: 80

Registration Number: NCT00004423

Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22

Phase 2

Completed

Conditions: Cocaine-Related Disorders
Opioid-Related Disorders

First Posted Date: 1999-09-21

Last Posted Date: 2015-06-03

Lead Sponsor: University of Vermont

Registration Number: NCT00000240

Locations: 🇺🇸
Treatment Research Center, Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy